Keperawatan dan Faktor-Faktor yang Mempengaruhi Luka Nekrotik Usus pada Pasien Covid-19

Sitti Syabariyah; Afdhalun Nisa; Nina Gartika

doi:10.56741/bikk.v2i01.126

PDF

Published: Jan 9, 2023

DOI: https://doi.org/10.56741/bikk.v2i01.126

Keywords:

COVID-19, Faktor Usia, Faktor Komorbiditas, Luka Nekrotik

Sitti Syabariyah

Universitas 'Aisyiyah Bandung

Afdhalun Nisa

Bandung Kiwari Hospital

Nina Gartika

Universitas Aisyiyah Bandung

Abstract

Pasien COVID-19 yang parah sering mengalami hiperinflamasi. Hiperinflamasi sistemik dapat menyebabkan mikrotrombosis sebagai akibat hiperkoagulasi. Hal ini dapat menyebabkan iskemia pada jaringan pencernaan dan akhirnya menimbulkan luka nekrotik usus. Penelitian ini mengidentifikasi faktor apa saja yang mempengaruhi timbulnya luka nekrotik usus pada pasien COVID-19 serta implikasi keperawatnnya. Analisis dilakukan dengan strategi pencarian pada tiga studi yaitu case study, systematic review dan meta-analysis yang disusun dari Maret 2021 hingga Juli 2021. Database yang digunakan Google Scholar, Pubmed, Research Gate dan Science Direct yang setidaknya membahas mekanisme luka nekrotik usus dan presentasi kasus luka nekrotik usus pada pasien COVID-19. Hasil penelitian menujukkan pasien COVID-19 yang berjenis kelamin laki, kelompok usia dewasa dengan komorbid diabetes memiliki resiko tinggi terhadap masalah luka nekrotik usus dan untuk tata laksana, keperawatan kritis dapat menjadi bidang yang perlu dipilih oleh perawat selama memberikan perawatan pada pasien. Diharapkan penelitian ini dapat menjadi referensi dalam pengembangan ilmu keperawatan mengenai mekanisme luka nekrotik usus pada pasien COVID-19.

Downloads

Download data is not yet available.

How to Cite

Syabariyah, S., Nisa, A., & Gartika, N. (2023). Keperawatan dan Faktor-Faktor yang Mempengaruhi Luka Nekrotik Usus pada Pasien Covid-19. Buletin Ilmu Kebidanan Dan Keperawatan, 2(01), 1–14. https://doi.org/10.56741/bikk.v2i01.126

Issue

Vol. 2 No. 01 (2023): Buletin Ilmu Kebidanan dan Keperawatan

Section

Articles

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Author Biographies

Sitti Syabariyah, Universitas 'Aisyiyah Bandung

Dr. Sitty Syabariyah, S.Kp., MS.Biomed. adalah dosen di Fakultas Ilmu Kesehatan, Universitas 'Aisyiyah Bandung. Gelar doktor diperoleh dari Universitas Indonesia. Keahliannya adalah dalam keperawatan, kesehatan, manajemen rumah sakit, dan manajemen risiko. Beliau telah menerbitkan banyak artikel di jurnal internasional. Pernah menjadi dosen tamu di University Teknologi Mara (UiTM) Malaysia. Saat ini menjadi reviewer dari Journal of Health Sciences and Medical Development (email: sittisyabariyah@unisa-bandung.ac.id).

Afdhalun Nisa, Bandung Kiwari Hospital

Afdhalun Nisa adalah perawat praktisi di Rumah Sakit Bandung Kiwari, Jawa Barat, Indonesia. Dalam kajian ini, beliau adalah anggota peneliti (email: ners.afdhalunnisa@gmail.com).

Nina Gartika, Universitas Aisyiyah Bandung

Nina Gartika adalah dosen di Fakultas Ilmu Kesehatan, Universitas 'Aisyiyah Bandung. Penelitiannya terkait dengan keperawatan. Beliau pernah bekerja sebagai dosen tamu di Universiti Teknologi Mara (UiTM) Malaysia. Minat penelitiannya meliputi keperawatan geriatri dan keperawatan medis-bedah (email: nina.gartika@unisa-bandung.ac.id).

Received 2022-08-31
Accepted 2023-01-03
Published 2023-01-09

Plaudit

References

World Health Organization (WHO), “NOVEL CORONAVIRUS: Pertayaan dan Jawaban Terkait Coronavirus,” WHO Indonesia, 2020.

M. Naveed et al., “Who is a potential risk groups to coronavirus disease 2019 (COVID-19) A-Review,” New Microbes New Infect, vol. 2019, p. 100849, 2021, doi: 10.1016/j.nmni.2021.100849.

O. W. in D. JHU CSSE COVID-19 Data, “Berita Virus corona ( COVID-19 ) Statistik Berita Visualisasi Kasus,” News Google, 2021.

Pusat Informasi dan Koordinasi Covid-19 Provinsi Jawa Barat, “Sebaran Kasus Covid-19 di Jawa Barat,” Pusat Informasi dan Koordinasi Covid-19 Provinsi Jawa Barat, 2021.

M. Hoffmann et al., “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor,” Cell, vol. 181, no. 2, pp. 271-280.e8, Apr. 2020, doi: 10.1016/j.cell.2020.02.052.

Y. Hayashi et al., “The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis,” J Gastroenterol, vol. 56, no. 5, pp. 409–420, May 2021, doi: 10.1007/s00535-021-01778-z.

R. A. Ghayda et al., “Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis,” Int J Environ Res Public Health, vol. 17, no. 14, p. 5026, Jul. 2020, doi: 10.3390/ijerph17145026.

R. Mao et al., “Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.,” Lancet Gastroenterol Hepatol, vol. 5, no. 7, pp. 667–678, 2020, doi: 10.1016/S2468-1253(20)30126-6.

K. T. Silangen, B. J. Waleleng, and F. E. N. Wantania, “Gejala Gastrointestinal pada Pasien COVID-19,” e-CliniC, vol. 9, no. 2, p. 279, 2021, doi: 10.35790/ecl.v9i2.32851.

F. Xiao, M. Tang, X. Zheng, Y. Liu, X. Li, and H. Shan, “Evidence for Gastrointestinal Infection of SARS-CoV-2,” Gastroenterology, vol. 158, no. 6, pp. 1831-1833.e3, May 2020, doi: 10.1053/j.gastro.2020.02.055.

M. Ignat et al., “Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity,” Surgery, vol. 168, no. 1, pp. 14–16, Jul. 2020, doi: 10.1016/j.surg.2020.04.035.

H. A. Willim, A. T. Hardigaloeh, and A. I. Supit, “Koagulopati pada Coronavirus Disease -2019 ( COVID-19 ): Tinjauan pustaka,” vol. 11, no. 3, pp. 749–756, 2020, doi: 10.15562/ism.v11i3.766.

C. Lodigiani et al., “Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.,” Thromb Res, vol. 191, pp. 9–14, 2020, doi: 10.1016/j.thromres.2020.04.024.

M. Levi, J. Thachil, T. Iba, and J. H. Levy, “Coagulation abnormalities and thrombosis in patients with COVID-19.,” Lancet Haematol, vol. 7, no. 6, pp. e438–e440, 2020, doi: 10.1016/S2352-3026(20)30145-9.

B. S. Joly, V. Siguret, and A. Veyradier, “Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.,” Intensive Care Med, vol. 46, no. 8, pp. 1603–1606, Aug. 2020, doi: 10.1007/s00134-020-06088-1.

R. M. Gartland and G. C. Velmahos, “Bowel Necrosis in the Setting of COVID-19,” Journal of Gastrointestinal Surgery, vol. 24, no. 12, pp. 2888–2889, 2020, doi: 10.1007/s11605-020-04632-4.

E. A. Campbell and M. Silberman, “Bowel Necrosis,” StatPearls, pp. 1–5, 2020.

D. A. Soeselo, W. Hambali, and S. Theresia, “Bowel necrosis in patient with severe case of COVID-19: a case report,” BMC Surg, vol. 21, no. 1, pp. 1–5, 2021, doi: 10.1186/s12893-021-01104-7.

M. Z. Mir, A. Mashhadi, M. Jahantigh, and S. J. Seyedi, “Bowel necrosis associated with COVID-19 pneumonia: A report of two cases,” Radiol Case Rep, vol. 16, no. 4, pp. 819–823, Apr. 2021, doi: 10.1016/j.radcr.2021.01.043.

R. M. Gartland and G. C. Velmahos, “Bowel Necrosis in the Setting of COVID-19,” Journal of Gastrointestinal Surgery, vol. 24, no. 12, pp. 2888–2889, 2020, doi: 10.1007/s11605-020-04632-4.

D. A. Soeselo, W. Hambali, and S. Theresia, “Bowel necrosis in patient with severe case of COVID-19: a case report,” BMC Surg, vol. 21, no. 1, pp. 1–5, 2021, doi: 10.1186/s12893-021-01104-7.

E. A. Campbell and M. Silberman, “Bowel Necrosis,” StatPearls, pp. 1–5, 2020.

American Academy of Pediatrics and Children’s Hospital Association, “Children and COVID-19 : State Data Report,” 2020.

N. Dhochak, T. Singhal, S. K. Kabra, and R. Lodha, “Why Children Fare Better Than Adults,” The Indian Journal of Pediatrics, vol. 416, 2020.

L. R. A. Schouten, M. J. Schultz, A. H. van Kaam, N. P. Juffermans, A. P. Bos, and R. M. Wösten-van Asperen, “Association between Maturation and Aging and Pulmonary Responses in Animal Models of Lung Injury,” Anesthesiology, vol. 123, no. 2, pp. 389–408, Aug. 2015, doi: 10.1097/ALN.0000000000000687.

C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “The Hallmarks of Aging,” Cell, vol. 153, no. 6, pp. 1194–1217, Jun. 2013, doi: 10.1016/j.cell.2013.05.039.

R. A. Ghayda et al., “Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis,” Int J Environ Res Public Health, vol. 17, no. 14, p. 5026, Jul. 2020, doi: 10.3390/ijerph17145026.

P. Conti and A. Younes, “CORONAVIRUS COV-19/SARS-CoV-2 AFFECTS WOMEN LESS THAN MEN: CLINICAL RESPONSE TO VIRAL INFECTION,” J Biol Regul Homeost Agents, vol. 34, no. 2, pp. 339–343, 2020.

S. K. Das, “The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19),” Indian Journal of Clinical Biochemistry, vol. 35, no. 4, pp. 385–396, 2020, doi: 10.1007/s12291-020-00919-0.

S. Lim, J. H. Bae, H.-S. Kwon, and M. A. Nauck, “COVID-19 and diabetes mellitus: from pathophysiology to clinical management,” Nat Rev Endocrinol, vol. 17, no. 1, pp. 11–30, Jan. 2021, doi: 10.1038/s41574-020-00435-4.

Yuliana, “Wellness and Healthy Magazine,” Parque de los afectos. Jóvenes que cuentan, vol. 2, no. February, pp. 124–137, 2020.

W. Guo et al., “Diabetes is a risk factor for the progression and prognosis of COVID-19,” Diabetes Metab Res Rev, vol. 36, no. 7, Oct. 2020, doi: 10.1002/dmrr.3319.

C. V. Ugwueze, B. C. Ezeokpo, B. I. Nnolim, E. A. Agim, N. C. Anikpo, and K. E. Onyekachi, “COVID-19 and Diabetes Mellitus: The Link and Clinical Implications,” Dubai Diabetes and Endocrinology Journal, vol. 26, no. 2, pp. 69–77, 2020, doi: 10.1159/000511354.

W. Guo et al., “Diabetes is a risk factor for the progression and prognosis of COVID-19,” Diabetes Metab Res Rev, vol. 36, no. 7, Oct. 2020, doi: 10.1002/dmrr.3319.

M. Ignat et al., “Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity,” Surgery, vol. 168, no. 1, pp. 14–16, Jul. 2020, doi: 10.1016/j.surg.2020.04.035.

Y. Wan, J. Shang, R. Graham, R. S. Baric, and F. Li, “Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.,” J Virol, vol. 94, no. 7, 2020, doi: 10.1128/JVI.00127-20.

R. Hosseinzadeh et al., “Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?,” Clin Hypertens, vol. 27, no. 1, pp. 1–7, 2021, doi: 10.1186/s40885-021-00161-7.

Z. Y. Zu et al., “Coronavirus Disease 2019 (COVID-19): A Perspective from China.,” Radiology, vol. 296, no. 2, pp. E15–E25, 2020, doi: 10.1148/radiol.2020200490.

R. Kreutz et al., “Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19,” Cardiovasc Res, vol. 116, no. 10, pp. 1688–1699, Aug. 2020, doi: 10.1093/cvr/cvaa097.

A. Gunawan, K. Prahasanti, and M. R. Utama, “Pengaruh Komorbid Hipertensi Terhadap Severitas Pasien Yang Terinfeksi Covid 19,” Jurnal Implementa Husada, vol. 1, no. 2, p. 136, 2020, doi: 10.30596/jih.v1i2.4972.

S. K. Das, “The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19),” Indian Journal of Clinical Biochemistry, vol. 35, no. 4, pp. 385–396, 2020, doi: 10.1007/s12291-020-00919-0.

A. Tamara and D. L. Tahapary, “Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.,” Diabetes Metab Syndr, vol. 14, no. 4, pp. 655–659, doi: 10.1016/j.dsx.2020.05.020.

N. W. Aqmarina, E. D. Risanti, I. Novita, N. Mahmudah, and S. Wahyu, “Obesitas Sebagai Faktor Risiko Keparahan Pada COVID-19,” pp. 371–377, 2021.

B. De Almeida-Pititto et al., “Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis,” Diabetol Metab Syndr, vol. 12, no. 1, pp. 1–12, 2020, doi: 10.1186/s13098-020-00586-4.

B. Wang, R. Li, Z. Lu, and Y. Huang, “Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis,” Aging, vol. 12, no. 7, pp. 6049–6057, Apr. 2020, doi: 10.18632/aging.103000.

M. G. Mazza et al., “Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors,” Brain Behav Immun, vol. 89, pp. 594–600, Oct. 2020, doi: 10.1016/j.bbi.2020.07.037.

T. Almira, “Depresi Dan Kecemasan Pada Penderita Corona Virus Disease 2019,” Jurnal Penelitian Perawat Profesional, vol. 2, no. 3, pp. 355–360, 2020.

L. S. Khesrani, karima Chana, F. Z. Sadar, A. Dahdouh, Y. Ladjadj, and D. Bouguermouh, “Intestinal ischemia secondary to Covid-19,” J Pediatr Surg Case Rep, vol. 61, p. 101604, 2020, doi: 10.1016/j.epsc.2020.101604.

J. T. Astuti and S. Suyanto, “Implikasi Manajemen Keperawatan Dalam Penanganan Pasien Corona Virus Disease 19 (Covid-19): Literatur Review,” Medica Hospitalia : Journal of Clinical Medicine, vol. 7, no. 1A, pp. 288–297, 2020, doi: 10.36408/mhjcm.v7i1a.465.

D. Handayani, D. R. Hadi, F. Isbaniah, E. Burhan, and H. Agustin, “Corona Virus Disease 2019,” Jurnal Respirologi Indonesia, vol. 40, no. 2, pp. 119–129, Apr. 2020, doi: 10.36497/jri.v40i2.101.

R. T. Purba, M. P. Adhi, E. Kusumawardhani, R. Hardian, and A. L. Tobing, “Potensi Pemberian Tocilizumab pada Pasien COVID-19 Di ICU RSUD Ulin Banjarmasin,” JAI (Jurnal Anestesiologi Indonesia), vol. 12, no. 3, pp. 17–33, 2020, doi: 10.14710/jai.v12i3.32905.

D. Bruce-Hickman, S. M. Sajeed, Y. H. Pang, C. S. Seow, W. Chen, and M. Gulati Kansal, “Bowel ulceration following tocilizumab administration in a COVID-19 patient,” BMJ Open Gastroenterol, vol. 7, no. 1, pp. 3–7, 2020, doi: 10.1136/bmjgast-2020-000484.

D. Handayani, D. R. Hadi, F. Isbaniah, E. Burhan, and H. Agustin, “Corona Virus Disease 2019,” Jurnal Respirologi Indonesia, vol. 40, no. 2, pp. 119–129, Apr. 2020, doi: 10.36497/jri.v40i2.101.

J. T. Astuti and S. Suyanto, “Implikasi Manajemen Keperawatan Dalam Penanganan Pasien Corona Virus Disease 19 (Covid-19): Literatur Review,” Medica Hospitalia : Journal of Clinical Medicine, vol. 7, no. 1A, pp. 288–297, 2020, doi: 10.36408/mhjcm.v7i1a.465.

M. Z. Mir, A. Mashhadi, M. Jahantigh, and S. J. Seyedi, “Bowel necrosis associated with COVID-19 pneumonia: A report of two cases,” Radiol Case Rep, vol. 16, no. 4, pp. 819–823, Apr. 2021, doi: 10.1016/j.radcr.2021.01.043.

P. Keshavarz, F. Rafiee, H. Kavandi, S. Goudarzi, F. Heidari, and A. Gholamrezanezhad, “Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation,” Clin Imaging, vol. 73, no. December, pp. 86–95, 2021, doi: 10.1016/j.clinimag.2020.11.054.

W. Hassan and H. K. A. Ramadan, “COVID-19 and pneumatosis intestinalis: An early sign of intestinal ischemia,” Digestive and Liver Disease, vol. 53, no. 3, pp. 289–290, 2021, doi: 10.1016/j.dld.2020.10.036.

L. S. Khesrani, karima Chana, F. Z. Sadar, A. Dahdouh, Y. Ladjadj, and D. Bouguermouh, “Intestinal ischemia secondary to Covid-19,” J Pediatr Surg Case Rep, vol. 61, p. 101604, 2020, doi: 10.1016/j.epsc.2020.101604.

C. Y. Chiu, A. Sarwal, A. M. Mon, Y. E. Tan, and V. Shah, “Gastrointestinal: COVID-19 related ischemic bowel disease,” Journal of Gastroenterology and Hepatology (Australia), vol. 36, no. 4, p. 850, 2021, doi: 10.1111/jgh.15254.

A. Dewi, B. Utomo, and S. Rachman, Panduan Asuhan Keperawatan (PAK) pada Pasien Kritis dengan COVID-19. Surabaya: Pusat Penebitan dan Percetakan Universitas Airlangga, 2020.

P. Balani, A. S. Bhuiyan, V. N. Dalal, and G. S. Maheshwari, “Early Detection and Successful Management of Acute Mesenteric Ischaemia in Symptomatic COVID-19 Patient,” Indian Journal of Surgery, Apr. 2021, doi: 10.1007/s12262-021-02839-6.

C. Y. Chiu, A. Sarwal, A. M. Mon, Y. E. Tan, and V. Shah, “Gastrointestinal: COVID-19 related ischemic bowel disease,” Journal of Gastroenterology and Hepatology (Australia), vol. 36, no. 4, p. 850, 2021, doi: 10.1111/jgh.15254.

Article Sidebar

Main Article Content